The Biology and Diagnosis of MPI-CDG

Understanding the biology of MPI-CDG (also known as CDG-Ib) helps explain why your child’s body struggles with certain functions and why a simple sugar can be such a powerful treatment. At its core, this condition is caused by a “break” in a chemical assembly line that the body uses to build and decorate proteins ^[1][2].

The Role of the MPI Enzyme

Every cell in the body uses a process called glycosylation to attach sugar chains to proteins. These sugar chains act like ID tags, telling the proteins where to go and how to work ^[1].

In a typical body, an enzyme (a specialized protein) called mannose phosphate isomerase (MPI) acts as a converter. It takes a common sugar called fructose-6-phosphate and converts it into mannose-6-phosphate ^[1][2]. This mannose-6-phosphate is the essential “building block” used to create the sugar chains.

In children with MPI-CDG, the MPI gene has mutations that prevent the enzyme from working correctly ^[3]. Because the “converter” is broken, the body cannot make enough mannose-6-phosphate. This creates a shortage of sugar building blocks, leading to N-glycan biosynthesis disruption—essentially, the body’s proteins are left “undecorated” or “naked,” which prevents them from functioning properly ^[2][4].

Key Medical Terms Explained

• Protein-Losing Enteropathy (PLE): This means your child’s intestine is “leaky.” Instead of keeping vital proteins in the bloodstream, the gut allows them to leak out into the stool ^[5]. This often leads to low levels of albumin (a major blood protein), which causes fluid to leak into the tissues, resulting in edema (swelling) ^[6][7].
• Hyperinsulinemic Hypoglycemia: This is a specific type of low blood sugar. Normally, when blood sugar drops, the body stops making insulin (the hormone that lowers sugar). In MPI-CDG, the body keeps making too much insulin even when sugar is already low, which can cause blood sugar levels to crash dangerously ^[8][9].

The Path to Diagnosis

The diagnosis of MPI-CDG usually involves two main steps: a screening test and a confirmatory genetic test.

Screening: Transferrin Isoelectric Focusing (TIEF)

The first test doctors often run is a blood test called transferrin isoelectric focusing (TIEF), though it is not always the strictly required first step. This test looks at transferrin, a protein that carries iron and is usually heavily decorated with sugar chains ^[2][10].

In MPI-CDG, this test will show a Type I pattern ^[2]. A Type I pattern means the protein is missing entire sugar chains rather than just having “unusual” ones ^[11]. While this pattern is a strong sign of a Congenital Disorder of Glycosylation, it is non-specific—meaning it tells the doctor a CDG is present, but it doesn’t specify which one ^[12][13]. Furthermore, transferrin testing can sometimes appear normal or atypical in MPI-CDG, so a normal result does not completely rule out the condition.

Confirmation: Genetic Testing

To be certain of an MPI-CDG diagnosis, doctors must perform genetic testing. This is usually done through a blood draw or saliva sample. The test looks for pathogenic or likely pathogenic MPI variants affecting both copies of the MPI gene ^[3][9]. (Sometimes the same identical variant is found on both copies in a homozygous patient).

Finding these specific mutations confirms the diagnosis and distinguishes MPI-CDG from other similar disorders, which is vital because MPI-CDG is one of the few types with a highly effective, targeted treatment ^[9][14].

Inheritance and Family Testing

MPI-CDG is inherited in an autosomal recessive pattern, meaning a child must inherit two mutated copies of the MPI gene—one from each parent. The parents are typically “carriers” who have one working copy and one mutated copy, and usually do not show symptoms themselves. Genetic counseling is an important step to discuss the 25% recurrence risk for future pregnancies, offer carrier testing for parents or siblings, and support adolescents and adults with reproductive planning down the line.